Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Invested Capital (2016 - 2025)

Neuronetics (STIM) has disclosed Invested Capital for 10 consecutive years, with $28.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital rose 202.27% to $28.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $28.4 million, a 202.27% increase, with the full-year FY2024 number at $28.7 million, down 16.04% from a year prior.
  • Invested Capital was $28.4 million for Q3 2025 at Neuronetics, down from $32.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $126.2 million in Q3 2021 to a low of $9.4 million in Q3 2024.
  • A 5-year average of $56.2 million and a median of $45.5 million in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: skyrocketed 234.11% in 2021, then crashed 75.27% in 2024.
  • Neuronetics' Invested Capital stood at $85.2 million in 2021, then decreased by 17.6% to $70.2 million in 2022, then plummeted by 51.29% to $34.2 million in 2023, then fell by 16.04% to $28.7 million in 2024, then fell by 1.22% to $28.4 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Invested Capital are $28.4 million (Q3 2025), $32.5 million (Q2 2025), and $40.5 million (Q1 2025).